Fingerprint
Dive into the research topics of 'Randomized, double-blind, phase 3 trial of enzastaurin versus placebo in patients achieving remission after first-line therapy for high-risk diffuse large B-Cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically